tiprankstipranks
Santen Pharmaceutical Co Ltd (JP:4536)
:4536
Japanese Market

Santen Pharmaceutical Co (4536) Income Statement

Compare
0 Followers

Santen Pharmaceutical Co Income Statement

Last quarter (Q1 2024), Santen Pharmaceutical Co's total revenue was ¥74.77B, an increase of 3.29% from the same quarter last year. In Q1, Santen Pharmaceutical Co's net income was ¥10.63B. See Santen Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 301.96B¥ 279.04B¥ 266.26B¥ 249.60B¥ 241.56B
Gross Profit
¥ 163.88B¥ 166.09B¥ 156.59B¥ 151.38B¥ 146.72B
Operating Expenses
¥ 111.97B¥ 169.18B¥ 120.70B¥ 138.47B¥ 113.19B
Depreciation and Amortization
¥ 18.18B¥ 17.25B¥ 17.05B¥ 17.92B¥ 16.57B
EBITDA
¥ 56.46B¥ 14.30B¥ 54.52B¥ 30.01B¥ 49.41B
Operating Income
¥ 38.54B¥ -3.09B¥ 35.89B¥ 12.92B¥ 33.53B
Other Income/Expenses
¥ -8.67B¥ -2.71B¥ -270.00M¥ -499.00M¥ -1.44B
Pretax Income
¥ 29.87B¥ -5.80B¥ 35.62B¥ 12.42B¥ 32.09B
Net Income
¥ 26.64B¥ -14.95B¥ 27.22B¥ 6.83B¥ 23.62B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 72.62¥ -38.58¥ 68.07¥ 17.10¥ 59.16
Diluted EPS
¥ 72.37¥ -38.58¥ 67.97¥ 17.06¥ 59.01
Weighted Average Shares Outstanding
366.89M 387.42M 399.77M 399.46M 399.16M
Weighted Average Shares Outstanding (Diluted)
368.14M 387.42M 400.46M 400.39M 400.25M
Currency in JPY

Santen Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis